The following is a summary of “Association of Glucagon-like Peptide-1 Receptor Agonists with Optic Nerve and Retinal Adverse ...

The two drugs are metformin, one of the most widely used diabetes medications, and the GLP-1 class of medications that include Ozempic, Mounjaro and Saxenda. A study of nearly 13,000 people with ...

glucagon-like peptide (GLP)-1 receptor agonist, or dipeptidyl peptidase-4 (DPP-4) inhibitor added to metformin, reported José Luchsinger, MD, MPH, of Columbia University Irving Medical Center in ...

GLP-1RA use initially lowered delirium risk but eventually heightened delirium risk after 5 years among patients with type 2 diabetes.

A new study finds a link between the use of antidiabetic drugs like SGLT2 inhibitors and a reduced risk for atrial ...

Shares of Novo Nordisk Inc. (NYSE: NVO) are trading lower Tuesday after a new study raised concerns about a potential link ...

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

Humans have spent thousands of years experimenting with weight loss aids. While Ozempic and Wegovy may be generating ...

Semaglutide use may be increasing worldwide rates of ischemic optic neuropathy and retinal adverse events, a study suggests.